Studies on an Oxidative 1,4-Addition to s-trans-1,3-Dienes
FULL PAPER
CDCl3): δ ϭ 35.57 ppm. C25H31O4P (426.49, 426.1803). ESI MS:
m/z ϭ [C25H31O4P ϩ H]ϩ calcd. 427.2033, found 427.2037.
Ar), 172.54 (CO) ppm. 31P NMR (80 MHz, CDCl3): δ ϭ 29.93
ppm. C25H31O4P (426.49, 426.1803). FAB MS: m/z ϭ 427.1 [M ϩ
H]ϩ, 449.0 [M ϩ Na]ϩ.
(1S*,4R*,1ЈR*)-[4-(Diphenylphosphanoyl)-4-(1-hydroxy-
pentyl)cyclopent-2-enyl]acetic Acid (rac-32): IR (KBr): ν˜ ϭ 3543,
Methyl (Z)-(1R*)-(4-Pentylidenecyclopent-2-enyl)acetate (rac-7a):
A solution of KOtBu (9 mg, 0.07 mmol) in THF (1 mL) was added
slowly under Ar to a solution of rac-31 (26 mg, 0.06 mmol) in THF
(3 mL). The mixture was stirred for 0.5 h and then water was ad-
ded. A usual workup (Et2O) followed by FC (pentane/Et2O,1:1)
furnished rac-7a (11 mg, 95 %). 1H NMR (400 MHz, CD3OD, H,H
COSY, NOEDIF): δ ϭ 0.90 (t, 3 H, 5Ј-CH3), 1.34 (m, 4 H, 4Ј-
CH2, 3Ј-CH2), 2.14 (m, 3 H, 2Ј-CH2, 5-Ha), 2.26 and 2.39 (AB of
ABX, JAX ϭ 6, JBX ϭ 7, JAB ϭ 16 Hz, m, 2 H, CH2COOMe) 2.73
(m, 1 H, 5-Hb), 3.12 (m, 1 H, 1-H), 3.66 (s, 3 H, CH3), 5.14 (t, 1
H, 1Ј-H), 6.00 (m, 1 H, 2-H), 6.41 (m, 1 H, 3-H) ppm. C13H2O2
(208.30, 208.1463).
1
1756, 1227, 1117 cmϪ1. H NMR (400 MHz, CDCl3, H,H COSY,
HMQC, HMBC): δ ϭ 0.82 (t, 3 H, 5Ј-CH3), 1.20 (m, 2 H, 4Ј-CH2),
1.24 (m, 3 H, 3Ј-CH2, 2Ј-Ha), 1.51 (m, 1 H, 2Ј-Hb), 1.58 and 1.92
(AB of ABX, JAX ϭ 7, JBX ϭ 8, JAB ϭ 17.0 Hz, m, 2 H,
CH2COOMe), 1.52 (m, 1 H, 5-Ha), 2.24 (m, 1 H, 5-Hb), 3.17 (m,
1 H, 1-H), 3.61 (m, 3 H, CH3), 3.90 (dt, JH,H ϭ 10, JP-H ϭ 3 Hz,
1 H, 1Ј-H), 5.97 (m, 1 H, 3-H), 6.19 (m, 1 H, 2-H), 7.67 (m, 5 H,
Ar-H), 7.74 (m, 2 H, Ar-H), 7.92 (m, 2 H, Ar-H) ppm. 13C NMR
(50 MHz, CDCl3): δ ϭ 14.14 (C-5Ј), 22.67 (C-4Ј), 28.61 (C-2Ј),
32.00 (C-3Ј), 35.26 (C-5), 39.52 (CH2COOMe), 42.83 (C-1), 51.65
1
3
(CH3), 76.18 (C-1Ј, d, JC,P ϭ 32 Hz), 128.93 (C-3, d, JC,P
ϭ
2
7.5 Hz), 138.17 (C-3, d, JC,P ϭ 11 Hz), 128.15Ϫ132.24 (C-Ar),
172.60 (CO) ppm. 31P NMR (80.96 MHz, CDCl3): δ ϭ 34.51 ppm.
C25H31O4P (426.49, 426.1803). ESI MS: m/z ϭ [C25H31O4P ϩ H]ϩ
calcd. 427.2033, found 427.2037.
Methyl (E)-(1R*)-(4-Pentylidenecyclopent-2-enyl)acetate (rac-10a):
rac-32a was converted into rac-10c as described for 7a. Yield:
1
11 mg, (95 %). H NMR (300 MHz, CDCl3/CD3OD, H,H COSY,
NOEDIF): δ ϭ 0.86 (t, 3 H, 5Ј-CH3), 1.28 (m, 4 H, 4Ј-CH2, 3Ј-
CH2), 2.00 (m, 3 H, 2Ј-CH2, 5-Ha), 2.28 and 2.39 (AB of ABX,
JAX ϭ 6, JBX ϭ 7, JAB ϭ 16 Hz, m, 2 H, CH2COOMe), 2.71 (m,
1 H, 5-Hb), 3.20 (m, 1 H, 1-H), 3.66 (s, 3 H, CH3), 5.28 (t, 1 H,
1Ј-H), 5.82 (dd, 1 H, 2-H), 6.06 (dd, 1 H, 3-H) ppm. C13H2O2
(208.30, 208.1463).
Reaction of rac-13b with Valeraldehyde in the Presence of Chlorotit-
anium Triisopropoxide:
A freshly prepared solution of LDA
(0.43 mmol) in THF was added slowly to a solution of rac-13b
(450 mg, 0.40 mmol) in THF (2 mL) cooled to Ϫ80 °C. The mix-
ture was stirred at Ϫ80 °C for 0.5 h and a solution of [Ti(iOPr)3Cl]
(3.44 mL, 0.48 mmol, THF) was added. After stirring for 2 h at Saponification of rac-7a: A solution of barium hydroxide (143 mg,
Ϫ80 °C, valeraldehyde (0.13 mL, 1.2 mmol) was added. After stir-
0.52 mmol) in MeOH (1 mL) was added under Ar to a solution of
ring for 1 h, the mixture was warmed slowly to room temp. Sat. aq. rac-7a (11 mg, 0.052 mmol) in MeOH (2 mL). The mixture was
NH4ClϪKF (5 mL) was added. Usual workup (CH2Cl2) followed stirred for 3 h and then 0.1 HCl (3 mL) was added. A usual
by FC (EtOAc) and HPLC (EtOAc/pentane, 2:1; flow rate: 10 mL/
workup (Et2O) and concentration under vacuum under Ar gave the
min) furnished rac-31 (53 mg, 33 %, based on consumed rac-13b) crude product rac-7b (7.4 mg, 85 %), which was used in the next
and rac-32 (46 mg, 38 %, based on consumed rac-13b) as colourless
oils and starting material rac-13b (287 mg).
step without purification. Compound rac-10a was converted into
rac-10b as described for 7b. Yield: 80 % (7.5 mg).
(3aR*,6aS*,1ЈS*)-5-(1-Hydroxypentyl)-3,3a,4,6a-tetrahydrocyclo-
penta[b]furan-2-one (rac-8) by Oxidation of rac-7b with H2O2/Di-
phenyl Diselenide: A solution of diphenyl diselenide (1 mg, 3.8
µmol) in CH2Cl2 (1 mL) and aq. 50 % H2O2 (4 µL) were added
under Ar to a solution of rac-7b (7.5 mg, 38 µmol) in CH2Cl2
(0.5 mL) at 0 °C. The mixture was stirred at 0 °C for 4 h and then
extracted with Et2O. The organic phase was washed with aq. 5 %
NaHCO3 (2 ϫ), dried (Na2SO4), filtered, and the solvents were
evaporated. FC (EtOAc) gave rac-8 (5 mg, 61 %). 1H NMR
(400 MHz, CDCl3, H,H COSY, HMQC, HMBC): δ ϭ 0.91 (t, 3
H, CH3), 1.36 (m, 4 H, 4Ј-CH2, 3Ј-CH2), 1.84 (m, 2 H, 4Ј-CH2),
2.20 (m, 2 H, 2-Ha, 4-Ha), 2.86 (m, 2 H, 2-Hb, 4-Hb), 3.20 (m, 1
H, 3a-H), 4.48 (br. s, 1 H, 1Ј-H), 4.70 (dd, J ϭ 1, J ϭ 6 Hz, H, 6a-
H), 5.70 (m, 1 H, 6-H). C12H18O3 (210.27, 210.1255), FAB MS:
m/z ϭ 211.2 [M ϩ H]ϩ.
(1S*,4R*,1ЈR*)-[4-(Diphenylphosphanoyl)-4-(1-hydroxypentyl)-
cyclopent-2-enyl]acetic Acid (rac-31): IR (KBr): ν˜ ϭ 3543, 1754,
1227, 1116 cmϪ1 1H NMR (600 MHz, CDCl3, H,H COSY,
.
HMQC, HMBC): δ ϭ 0.81 (t, 3 H, CH3-5Ј), 1.23 (m, 6 H, 4Ј-CH2,
3Ј-CH2, 2Ј-CH2), 1.93 (m, 1 H, 5-Ha), 2.21 (m, 2 H, CH2COOMe),
2.39 (m, 2 H, 5-Hb, 1Ј-H), 3.61 (s, 3 H, CH3), 4.13 (dt, JC,H ϭ 10,
JP-H ϭ 3 Hz, 1 H, 1Ј-H), 5.47 (m, 1 H, 3-H), 5.88 (m, 1 H, 2-H),
7.44 (m, 6 H, Ar-H), 7.90 (m, 4 H, Ar-H) ppm. 13C NMR
(50 MHz, CDCl3): δ ϭ 14.14 (C-5Ј), 22.91 (C-4Ј), 28.48 (C-3Ј),
2
31.17 (C-5, d, JC,P ϭ 6 Hz), 32.22 (C-2Ј, d, 2JC,P ϭ 9.5 Hz), 39.81
(CH2COOMe, d, 3JC,P ϭ 3 Hz), 41.82 (C-1, d, 3JC,P ϭ 2 Hz), 51.63
1
(CH3), 61.60 (C-4, d, JC,P ϭ 68 Hz), 71.92 (C-1Ј), 129.91 (C-3, d,
3JC,P ϭ 7.5 Hz), 138.72 (C-3, d, 2JC,P ϭ 11 Hz), 128.15Ϫ132.24 (C-
Ar), 172.46 (CO) ppm. 31P NMR (80.96 MHz, CDCl3): δ ϭ 21.00
ppm. C25H31O4P (426.49, 426.1803). FAB MS: m/z ϭ 427.0 [M ϩ
H]ϩ, 448.7 [M ϩ Na]ϩ.
(3aR*,6aS*,1ЈR*)-5-(1-Hydroxypentyl)-3,3a,4,6a-tetrahydrocyclo-
penta[b]furan-2-one (rac-11) by Oxidation of rac-10b with H2O2/Di-
phenyl Diselenide: rac-10b was converted into rac-11 as described
for rac-8. Yield: 5 mg (61 %). 1H NMR (400 MHz, CDCl3, H,H
COSY, HMQC, HMBC): δ ϭ 0.84 (t, 3 H, CH3), 1.28 (m, 4 H, 4Ј-
CH2, 3Ј-CH2), 1.51 (m, 2 H, 4Ј-CH2), 2.28 (m, 2 H, 2-Ha, 4-Ha),
2.76 (m, 2 H, 2-Hb, 4-Hb), 3.11 (m, 1 H, 3a-H), 4.20 (t, 1 H, 1Ј-H),
5.41 (m, 1 H, 6a-H), 5.68 (m, 1 H, 6-H) ppm. 13C NMR (100 MHz,
CDCl3): δ ϭ 12.95 (C-5Ј), 21.51 (C-4Ј), 26.47 (C-3Ј), 34.07 (C-2Ј),
34.46 (C-3a), 35.15 (C-2), 37.11 (C-4), 69.90 (C-1Ј), 88.28 (C-6a),
121.94 (C-6), 158.96 (CO) ppm. C12H18O3 (210.27, 210.1255). FAB
MS: m/z ϭ 211.2 [M ϩ H]ϩ, 193.1 [C12H8O2].
(1S*,4R*,1ЈR*)-[4-(Diphenylphosphanoyl)-4-(1-hydroxypentyl)-
cyclopent-2-enyl]acetic Acid (rac-32): IR (KBr): ν˜ ϭ 3543, 1754,
1227, 1116 cmϪ1 1H NMR (300 MHz, CDCl3, H,H COSY,
.
HMQC, HMBC): δ ϭ 0.83 (t, 3 H, 5Ј-CH3), 1.18 (m, 6 H, 4Ј-CH2,
3Ј-CH2, 2Ј-Ha), 1.47 (m, 2 H, 5-Ha and probably 2Ј-Hb), 1.73 (m,
2 H, CH2COOMe), 2.71 (m, 1 H, 5-Hb), 3.14 (m, 1 H, 1-H), 3.61
(s, 3 H, CH3), 3.99 (dt, JC,H ϭ 10, JP-H ϭ 3 Hz, 1 H, 1Ј-H), 5.45
(m, 1 H, 3-H), 5.85 (m, 1 H, 2-H), 7.44 (m, 6 H, Ar-H), 7.90 (m,
4 H, Ar-H) ppm. 13C NMR (50 MHz, CDCl3): δ ϭ 14.13 (C-5Ј),
2
22.87 (C-4Ј), 28.53 (C-3Ј), 30.84 (C-2Ј), 31.74 (C-5, d, JC,P
ϭ
3
9.5 Hz), 39.24 (CH2COOMe,), 43.14 (C-1, d, JC,P ϭ 4 Hz), 51.61
3
(CH3), 61.56 (C-4, d, JC,P ϭ 72 Hz), 72.44 (C-1Ј), 129.84 (C-3, d,
Oxidative Cyclization of rac-3 with a Catalytic Amount of Diphenyl
Diselenide and Hydrogen Peroxide: A solution of diphenyl diselen-
3JC,P ϭ 7.5 Hz), 138.77 (C-2, d, 2JC,P ϭ 11 Hz), 128.15Ϫ132.24 (C-
Eur. J. Org. Chem. 2003, 4640Ϫ4653
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4651